<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140257" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Oculocerebrorenal Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murdock</surname>
            <given-names>Narmien</given-names>
          </name>
          <aff>Boston University School of Medicine, Boston, MA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chou</surname>
            <given-names>Eva</given-names>
          </name>
          <aff>Walter Reed National Military Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Narmien Murdock declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Eva Chou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140257.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The oculocerebrorenal syndrome, also known as Lowe syndrome, was first described by Lowe et al. in 1952. It is a rare, X-linked recessive multisystem disorder that classically presents with a triad of congenital cataracts, renal failure, and intellectual delay. The causative OCRL gene encodes an enzyme involved in a number of intracellular processes. Researchers have elucidated a broad spectrum of phenotypic features linked to mutations in OCRL. This activity reviews the epidemiology, clinical features, and management of oculocerebrorenal syndrome. Additionally, it highlights the importance of an interprofessional team in caring for patients with this disorder.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the molecular genetics and pathophysiology of oculocerebrorenal syndrome.</p></list-item><list-item><p>Summarize the epidemiology of oculocerebrorenal syndrome and OCRL gene mutations.</p></list-item><list-item><p>Describe the clinical presentation of classic oculocerebrorenal syndrome and its phenotypic variants.</p></list-item><list-item><p>Outline the management strategies for patients with oculocerebrorenal syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140257&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140257">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140257.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>In the early 1950s, Lowe and colleagues defined a new syndrome in children that included the classic features of intellectual disability, organic aciduria, decreased renal ammonia production, bilateral cataracts, and glaucoma.<xref ref-type="bibr" rid="article-140257.r1">[1]</xref>&#x000a0;</p>
        <p>Since then, research has further characterized this disorder by identifying the presence of a Fanconi-type proximal renal tubulopathy, areflexia, and arthropathy.<xref ref-type="bibr" rid="article-140257.r2">[2]</xref><xref ref-type="bibr" rid="article-140257.r3">[3]</xref>&#x000a0;</p>
        <p>The oculocerebrorenal syndrome of Lowe syndrome is now known to be an X-linked recessive disorder impacting fundamental intracellular processes, explaining its multi-organ manifestations. Early diagnosis and supportive care are crucial to prevent life-threatening complications and maximize the quality of life.</p>
      </sec>
      <sec id="article-140257.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The oculocerebrorenal syndrome is caused by a mutation in the <italic toggle="yes">OCRL</italic> gene on chromosome Xq25-26. This gene encodes an inositol 5-phosphatase enzyme (OCRL-1), which is found primarily within clathrin-coated pits on the cell surface as well as within cellular organelles, particularly endosomes and the Golgi apparatus.<xref ref-type="bibr" rid="article-140257.r4">[4]</xref>&#x000a0;</p>
        <p>The enzyme converts phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 4-phosphate.<xref ref-type="bibr" rid="article-140257.r5">[5]</xref>&#x000a0;The proper function of OCRL-1 is essential for cellular processes such as protein trafficking, cell signaling, cell motility, and actin cytoskeleton remodeling.</p>
        <p>At least 200 mutations in the <italic toggle="yes">OCRL </italic>gene have been identified, most of which are frameshift, nonsense, and splice mutations. The <italic toggle="yes">OCRL</italic> variant type has not been shown to have a direct or reliable correlation with the phenotype or severity of the disease.<xref ref-type="bibr" rid="article-140257.r6">[6]</xref></p>
        <p>The <italic toggle="yes">OCRL </italic>gene mutation is transmitted in an X-linked recessive fashion, predominantly to males with a carrier mother. De novo <italic toggle="yes">OCRL </italic>mutations can arise in patients with no prior family history.<xref ref-type="bibr" rid="article-140257.r7">[7]</xref>&#x000a0;Although female carriers of an altered <italic toggle="yes">OCRL </italic>gene do not have the classic features of oculocerebrorenal syndrome, they have characteristic lenticular changes that can be seen on ophthalmologic examination.<xref ref-type="bibr" rid="article-140257.r8">[8]</xref>&#x000a0;Females with oculocerebrorenal manifestations have been reported, such as in patients with 45,X karyotype.<xref ref-type="bibr" rid="article-140257.r9">[9]</xref></p>
      </sec>
      <sec id="article-140257.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of oculocerebrorenal syndrome in the general population has been estimated at 1 in 500,000.<xref ref-type="bibr" rid="article-140257.r3">[3]</xref>&#x000a0;This disorder occurs almost exclusively in males and, in the United States, affects 1 to 10 males per 1 million people.</p>
      </sec>
      <sec id="article-140257.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with oculocerebrorenal syndrome present with abnormalities in multiple organ systems. These clinical findings will be reviewed in detail by the system.</p>
        <p>
<bold>The Nervous System</bold>
</p>
        <p>The burden of illness in patients with oculocerebrorenal syndrome is heavily based on the involvement of the peripheral and central nervous systems. Severe hypotonia and absence of deep tendon reflexes are some early clinical manifestations.<xref ref-type="bibr" rid="article-140257.r3">[3]</xref>&#x000a0;</p>
        <p>Infants may have impaired feeding as a consequence of weak or ineffective sucking. Hypotonia in infants also delays the achievement of motor milestones, such as ambulating independently. Patients are also prone to developing seizures, which can vary in type and severity. Intellectual disability is typical in most patients with Lowe syndrome and can range from mild to severe.<xref ref-type="bibr" rid="article-140257.r10">[10]</xref>&#x000a0;</p>
        <p>Patients tend to develop conduct disorders, such as aggression and obsessive-compulsive behavior. This maladaptive behavior interferes with daily functioning and can lead to self-injury.<xref ref-type="bibr" rid="article-140257.r11">[11]</xref>&#x000a0;Patients with low vision are particularly susceptible to conduct disorders and aggression.</p>
        <p>
<bold>The Ocular System</bold>
</p>
        <p>The visual potential in patients with oculocerebrorenal syndrome is low due to multiple phenotypic findings. The classic ocular manifestation is the presence of bilateral cataracts, which form in-utero and are often managed by cataract surgery&#x000a0;in infancy.<xref ref-type="bibr" rid="article-140257.r12">[12]</xref><xref ref-type="bibr" rid="article-140257.r13">[13]</xref>&#x000a0;</p>
        <p>Cataract formation in these patients is thought to be secondary to a genetic defect that affects the migration of the crystalline lens epithelial cells.<xref ref-type="bibr" rid="article-140257.r14">[14]</xref>&#x000a0;Less common ocular manifestations include X-linked infantile glaucoma, with or without buphthalmos. Glaucoma develops&#x000a0;within the first few decades of life and is difficult to treat.<xref ref-type="bibr" rid="article-140257.r15">[15]</xref>&#x000a0;It has been reported as one of the main etiologies of blindness in patients with Lowe syndrome.<xref ref-type="bibr" rid="article-140257.r16">[16]</xref>&#x000a0;</p>
        <p>Intraocular pressures can be&#x000a0;challenging to&#x000a0;treat, and patients are often on multiple topical medications. Surgical intervention may be required for more aggressive intraocular pressure control. Developing conjunctival or corneal keloids has been reported in Lowe syndrome, sometimes leading to vision-threatening corneal scars.&#x000a0;Other ophthalmic findings include nystagmus and strabismus.&#x000a0;</p>
        <p>Characteristic lenticular opacities, distributed radially in all layers of the cortex, have been linked to carriers of the <italic toggle="yes">OCRL </italic>gene.<xref ref-type="bibr" rid="article-140257.r17">[17]</xref><xref ref-type="bibr" rid="article-140257.r8">[8]</xref>&#x000a0;This highlights the importance of ophthalmologic examination in ascertaining a female&#x02019;s carrier status.&#x000a0;</p>
        <p>
<bold>The Renal System</bold>
</p>
        <p>In patients with oculocerebrorenal syndrome, the characteristic renal disease is characterized by Fanconi syndrome with proximal tubular dysfunction and progressive renal failure. Renal&#x000a0;disease may not be present at birth but may manifest&#x000a0;in early infancy. Impaired endocytosis in the proximal tubules results in low-molecular-weight (LMW) proteinuria, often in the nephrotic range.<xref ref-type="bibr" rid="article-140257.r4">[4]</xref>&#x000a0;</p>
        <p>Patients are also at risk of developing hyperchloremic metabolic acidosis.<xref ref-type="bibr" rid="article-140257.r18">[18]</xref>&#x000a0;Elevated urinary levels of amino acids and calcium have also been commonly reported in Lowe syndrome.&#x000a0;As a result of hypercalciuria, approximately half of patients will develop nephrolithiasis. Stones are often&#x000a0;composed of both calcium oxalate and calcium phosphate.<xref ref-type="bibr" rid="article-140257.r18">[18]</xref>&#x000a0;Renal phosphate wasting increases the risk for rickets and osteomalacia.<xref ref-type="bibr" rid="article-140257.r19">[19]</xref>&#x000a0;</p>
        <p>Chronic, progressive renal failure is a hallmark of Lowe syndrome and requires close monitoring of kidney function. By the fourth decade of life, most patients have stage 4-5 chronic kidney disease (CKD).<xref ref-type="bibr" rid="article-140257.r18">[18]</xref><xref ref-type="bibr" rid="article-140257.r20">[20]</xref></p>
        <p>
<bold>The Musculoskeletal System</bold>
</p>
        <p>Osteopenia, tenosynovitis, and debilitating arthropathy are&#x000a0;frequent musculoskeletal manifestations of oculocerebrorenal syndrome. Hypophosphatemia and metabolic acidosis can exacerbate osteopenia and lead to pathologic fractures.<xref ref-type="bibr" rid="article-140257.r4">[4]</xref>&#x000a0;Patients also present with stunted growth and short stature, which has been postulated to be the result of growth hormone deficiency.<xref ref-type="bibr" rid="article-140257.r21">[21]</xref>&#x000a0;Scoliosis has been reported in patients with Lowe syndrome and may worsen with age.<xref ref-type="bibr" rid="article-140257.r22">[22]</xref></p>
        <p>
<bold>Other Findings</bold>
</p>
        <p>Certain dermatologic findings reported in patients with Lowe syndrome&#x000a0;include benign cystic&#x000a0;lesions, thought to originate from hair follicles.<xref ref-type="bibr" rid="article-140257.r23">[23]</xref>&#x000a0;The etiology of these skin lesions is poorly understood but has been attributed to elevated levels of lysosomal enzymes in extracellular tissue.<xref ref-type="bibr" rid="article-140257.r24">[24]</xref>&#x000a0;Dental anomalies - such as delayed tooth eruption, enamel hypoplasia, and tooth impaction - have been linked to Lowe syndrome.<xref ref-type="bibr" rid="article-140257.r25">[25]</xref>&#x000a0;</p>
        <p>While puberty and testosterone levels are reportedly normal in most patients with Lowe syndrome, about one-third of males have cryptorchidism.<xref ref-type="bibr" rid="article-140257.r26">[26]</xref>&#x000a0;Dysfunction of primary&#x000a0;hemostasis has been recognized in Lowe syndrome and is postulated&#x000a0;to be&#x000a0;secondary to delayed platelet activation.<xref ref-type="bibr" rid="article-140257.r27">[27]</xref></p>
      </sec>
      <sec id="article-140257.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Infants with typical clinical findings of Lowe syndrome should undergo laboratory testing, particularly if presenting with failure to thrive. Serum and urine testing may reveal metabolic acidosis, hypokalemia, elevated creatinine, proteinuria, hypercalciuria, and/or aminoaciduria. In the presence of neurologic abnormalities, imaging may be warranted. Typical findings include periventricular and deep hyperintense lesions on T2-weighted magnetic resonance imaging (MRI). Mild ventriculomegaly may also be present.<xref ref-type="bibr" rid="article-140257.r4">[4]</xref>&#x000a0;Additional diagnostics may be indicated if other systemic symptoms or findings are present.</p>
        <p>The definitive diagnosis of Lowe syndrome is based on molecular genetic testing. Cultured skin fibroblasts demonstrate the reduced activity of inositol polyphosphate-5-phosphatase. Genetic testing can reveal a pathogenic variant of the <italic toggle="yes">OCRL </italic>gene. Antenatal testing is also available if Lowe syndrome is suspected. Ultrasound may reveal the presence of fetal cataracts.<xref ref-type="bibr" rid="article-140257.r12">[12]</xref>&#x000a0;Testing of maternal serum and amniotic fluid may show elevated levels of alpha-fetoprotein.<xref ref-type="bibr" rid="article-140257.r28">[28]</xref></p>
      </sec>
      <sec id="article-140257.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The oculocerebrorenal syndrome has systemic manifestations that can impact patient morbidity and mortality. Treatment focuses on optimizing function and preventing acute illness.</p>
        <p>
<bold>The Nervous and Musculoskeletal Systems</bold>
</p>
        <p>Treatment of hypotonia requires early physical therapy and rehabilitation. Maintaining articular mobility reduces the development of contractures. Prevention or treatment of osteomalacia involves oral supplementation of Vitamin D, calcitriol, and phosphate. Hypotonia resulting in dysphagia may necessitate tube feeding.</p>
        <p>Anticonvulsant therapy is required if seizures are present. Treatment of behavioral and psychiatric disorders&#x000a0;is best managed by multidisciplinary team care, which may include special education services, occupational therapy, and speech/language therapy. Some pharmacologic agents that have shown benefits in patients include stimulants, antipsychotics, and antidepressants.<xref ref-type="bibr" rid="article-140257.r3">[3]</xref></p>
        <p>
<bold>The Ocular System</bold>
</p>
        <p>Early cataract removal within the first three months of life is important to prevent amblyopia. Infants are often left aphakic and provided with spectacles or contact lenses to correct refractive error. In patients with infantile and/or aphakic glaucoma, intraocular pressures are often difficult to control with medical therapy alone. In many cases, surgical management is necessary.</p>
        <p>The most commonly reported glaucoma surgeries performed in this patient population are trabeculectomy and goniotomy. The next most common glaucoma surgery in these patients is aqueous tube shunt implantation.&#x000a0;Patching or extraocular muscle&#x000a0;surgery are used to treat&#x000a0;patients with strabismus. Corneal keloids can be surgically removed, particularly if they compromise visual acuity. However, some patients suffer from corneal scarring or require corneal transplantation.<xref ref-type="bibr" rid="article-140257.r16">[16]</xref>&#x000a0;Decreased vision secondary to corneal scarring also increases the risk of amblyopia.</p>
        <p>
<bold>The Renal System</bold>
</p>
        <p>Alkali supplementation, including sodium bicarbonate, is critical for patients with acidemia. Monitoring calcium and Parathyroid Hormone (PTH) helps prevent excess Vitamin D supplementation, which could increase hypercalciuria and the risk of nephrolithiasis.<xref ref-type="bibr" rid="article-140257.r3">[3]</xref>&#x000a0;</p>
        <p>Dialysis is&#x000a0;necessary for patients who advance to ESRD. Kidney transplantation in patients with oculocerebrorenal syndrome has been rarely reported in the literature.<xref ref-type="bibr" rid="article-140257.r29">[29]</xref></p>
      </sec>
      <sec id="article-140257.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Dent disease type 2</p>
          </list-item>
          <list-item>
            <p>Nance-Horan syndrome</p>
          </list-item>
          <list-item>
            <p>Congenital Rubella</p>
          </list-item>
          <list-item>
            <p>Smith-Lemi-Opitz syndrome (SLOS)</p>
          </list-item>
          <list-item>
            <p>Zellweger spectrum disorders</p>
          </list-item>
          <list-item>
            <p>Cystinosis</p>
          </list-item>
          <list-item>
            <p>Myotonic dystrophy</p>
          </list-item>
          <list-item>
            <p>Mucopolysaccharidoses</p>
          </list-item>
          <list-item>
            <p>Mitochondrial diseases</p>
          </list-item>
          <list-item>
            <p>Other diseases causing Fanconi syndrome (e.g., Wilson disease, tyrosinemia, galactosemia, glycogen storage diseases)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140257.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Visual prognosis is poor in patients with Lowe syndrome due to the high likelihood of amblyopia and glaucoma severity. Dysphagia resulting from hypotonia may be severe enough to require tube feeding. It also increases patient susceptibility to respiratory infections.</p>
        <p>Renal disease severity varies among patients and worsens with age. Patients typically live until the 2nd to 4th decade of life. Reduced life expectancy is most often a consequence of renal failure. Other frequent causes of death include respiratory illness, seizures, and infections.</p>
      </sec>
      <sec id="article-140257.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The oculocerebrorenal syndrome of Lowe affects multiple organ systems. The visual and neuromuscular&#x000a0;complications in this patient population significantly impact the patient's quality of life. Congenital cataracts may lead to amblyopia, but treatment with cataract&#x000a0;surgery&#x000a0;can also lead to secondary aphakic glaucoma, which can be severe and difficult to control.</p>
        <p>Patients are at risk for seizure disorders and febrile convulsions. Hypotonia may result in dysphagia,&#x000a0;leading to respiratory infections and complications. Mineral loss secondary to renal disease can&#x000a0;result in complications such as failure to thrive and hypophosphatemic rickets. Impaired hemostasis may lead to intra-operative complications in patients&#x000a0;requiring surgery.</p>
      </sec>
      <sec id="article-140257.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Lowe syndrome is an extremely rare genetic disorder that follows an X-linked recessive inheritance pattern. Affected males have not been reported to reproduce. De novo genetic mutations occur in about one-third of males affected by Lowe syndrome.<xref ref-type="bibr" rid="article-140257.r30">[30]</xref>&#x000a0;</p>
        <p>Genetic counseling is recommended for family members of the affected patient. Prenatal genetic testing is available to aid in counseling. Women with children&#x000a0;affected by&#x000a0;oculocerebrorenal syndrome should undergo prenatal genetic testing to assess for germline mosaicism.</p>
        <p>Due to the plethora of&#x000a0;systemic complications associated with Lowe syndrome, multidisciplinary evaluation and vigilant surveillance is essential. Parents with affected children should be educated on potential complications of hypotonia, such as feeding difficulties and delayed motor milestones from birth.&#x000a0;Conduct disorders, particularly in the setting of&#x000a0;low vision and intellectual impairment, can lead to self-destructive behaviors. Treatment includes behavior modification programs, individualized therapy, and antipsychotics.</p>
      </sec>
      <sec id="article-140257.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The oculocerebrorenal syndrome of Lowe is a systemic illness that impacts morbidity and mortality if poorly controlled. Optimizing the quality of life in patients requires a multidisciplinary and interprofessional team approach to treatment.</p>
        <p>Clinicians involved in the care of patients with Lowe syndrome may include pediatric ophthalmologists, nephrologists, neurologists, endocrinologists, and dentists. Geneticists and genetic counselors should work with the patient&#x02019;s family to discuss genetic testing options and results. Physical and speech therapists implement early rehabilitation and help achieve developmental milestones. Behavioral and child development specialists are also important members of the care team.</p>
        <p>All interprofessional team members must be able to contact other team members if they note any concerns or changes in the patient's condition. Further, every team member must keep accurate records of all observations and interactions with the patient, so the entire care team operates from the same accurate, up-to-date information and&#x000a0;better optimize care. [Level 5]</p>
      </sec>
      <sec id="article-140257.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140257&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140257">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/oculocerebrorenal-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140257">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140257/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140257">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-140257.s14">
        <title>References</title>
        <ref id="article-140257.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LOWE</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>TERREY</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>MacLACHLAN</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.</article-title>
            <source>AMA Am J Dis Child</source>
            <year>1952</year>
            <month>Feb</month>
            <volume>83</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-84</page-range>
            <pub-id pub-id-type="pmid">14884753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BICKEL</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>THURSBY-PELHAM</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Hyperamino-aciduria in Lignac-Fanconi disease, in galactosaemia and in an obscure syndrome.</article-title>
            <source>Arch Dis Child</source>
            <year>1954</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>145</issue>
            <fpage>224</fpage>
            <page-range>224-31</page-range>
            <pub-id pub-id-type="pmid">13159366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lowe syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2006</year>
            <month>May</month>
            <day>18</day>
            <volume>1</volume>
            <fpage>16</fpage>
            <pub-id pub-id-type="pmid">16722554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>B&#x000f6;kenkamp</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The oculocerebrorenal syndrome of Lowe: an update.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>12</issue>
            <fpage>2201</fpage>
            <page-range>2201-2212</page-range>
            <pub-id pub-id-type="pmid">27011217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jefferson</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Auethavekiat</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Majerus</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1995</year>
            <month>May</month>
            <day>23</day>
            <volume>92</volume>
            <issue>11</issue>
            <fpage>4853</fpage>
            <page-range>4853-6</page-range>
            <pub-id pub-id-type="pmid">7761412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hichri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rendu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Monnier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Coutton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dorseuil</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Poussou</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Baujat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Blanchard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nobili</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ranchin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Remesy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Satre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lunardi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes.</article-title>
            <source>Hum Mutat</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>379</fpage>
            <page-range>379-88</page-range>
            <pub-id pub-id-type="pmid">21031565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chou</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Chiou</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Identification of OCRL1 mutations in two Taiwanese Lowe syndrome patients.</article-title>
            <source>Acta Paediatr Taiwan</source>
            <year>2005</year>
            <season>Jul-Aug</season>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>226</fpage>
            <page-range>226-9</page-range>
            <pub-id pub-id-type="pmid">16381338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>R&#x000f6;schinger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Muntau</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Rudolph</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Roscher</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Kammerer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.</article-title>
            <source>Mol Genet Metab</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-22</page-range>
            <pub-id pub-id-type="pmid">10767176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Recker</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Reutter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lowe syndrome/Dent-2 disease: A comprehensive review of known and novel aspects.</article-title>
            <source>J Pediatr Genet</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-68</page-range>
            <pub-id pub-id-type="pmid">27625841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenworthy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Charnas</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Cognitive and behavioral profile of the oculocerebrorenal syndrome of Lowe.</article-title>
            <source>Am J Med Genet</source>
            <year>1993</year>
            <month>May</month>
            <day>15</day>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>297</fpage>
            <page-range>297-303</page-range>
            <pub-id pub-id-type="pmid">8488875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenworthy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Charnas</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of Lowe.</article-title>
            <source>Am J Med Genet</source>
            <year>1995</year>
            <month>Nov</month>
            <day>20</day>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>283</fpage>
            <page-range>283-90</page-range>
            <pub-id pub-id-type="pmid">8599350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daskalakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Anastasakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lyberopoulos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Antsaklis</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prenatal detection of congenital cataract in a fetus with Lowe syndrome.</article-title>
            <source>J Obstet Gynaecol</source>
            <year>2010</year>
            <month>May</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>409</fpage>
            <page-range>409-10</page-range>
            <pub-id pub-id-type="pmid">20455729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kruger</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hutchinson</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Peterseim</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bartholomew</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Cataracts and glaucoma in patients with oculocerebrorenal syndrome.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>121</volume>
            <issue>9</issue>
            <fpage>1234</fpage>
            <page-range>1234-7</page-range>
            <pub-id pub-id-type="pmid">12963605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathi</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Cibis</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Tripathi</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of cataracts in patients with Lowe's syndrome.</article-title>
            <source>Ophthalmology</source>
            <year>1986</year>
            <month>Aug</month>
            <volume>93</volume>
            <issue>8</issue>
            <fpage>1046</fpage>
            <page-range>1046-51</page-range>
            <pub-id pub-id-type="pmid">3763153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walton</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Katsavounidou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>CU</given-names>
              </name>
            </person-group>
            <article-title>Glaucoma with the oculocerebrorenal syndrome of Lowe.</article-title>
            <source>J Glaucoma</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-5</page-range>
            <pub-id pub-id-type="pmid">15870597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ning</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jabbehdari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prosseda</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shue</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Oculocerebrorenal syndrome of Lowe: Survey of ophthalmic presentations and management.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>966</fpage>
            <page-range>966-973</page-range>
            <pub-id pub-id-type="pmid">32340490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gardner</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Lowe's syndrome: identification of carriers by lens examination.</article-title>
            <source>J Med Genet</source>
            <year>1976</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>449</fpage>
            <page-range>449-54</page-range>
            <pub-id pub-id-type="pmid">1018304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bockenhauer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bokenkamp</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van't Hoff</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levtchenko</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kist-van Holthe</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tasic</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>1430</fpage>
            <page-range>1430-6</page-range>
            <pub-id pub-id-type="pmid">18480301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cheong</surname>
                <given-names>HI</given-names>
              </name>
            </person-group>
            <article-title>Renal manifestations of Dent disease and Lowe syndrome.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>243</fpage>
            <page-range>243-9</page-range>
            <pub-id pub-id-type="pmid">18038239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charnas</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Gahl</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>The oculocerebrorenal syndrome of Lowe.</article-title>
            <source>Adv Pediatr</source>
            <year>1991</year>
            <volume>38</volume>
            <fpage>75</fpage>
            <page-range>75-107</page-range>
            <pub-id pub-id-type="pmid">1927708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Lowe syndrome with extremely short stature: growth hormone deficiency may be the pathogeny.</article-title>
            <source>Growth Factors</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>3-4</issue>
            <fpage>170</fpage>
            <page-range>170-177</page-range>
            <pub-id pub-id-type="pmid">31576764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Lowe syndrome: a single center's experience in Korea.</article-title>
            <source>Korean J Pediatr</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>140</fpage>
            <page-range>140-8</page-range>
            <pub-id pub-id-type="pmid">24778696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erdogan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ismailogullari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Soyuer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ferahbas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poyrazoglu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Different seizure types and skin lesions in oculocerebrorenal syndrome of Lowe.</article-title>
            <source>J Child Neurol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-31</page-range>
            <pub-id pub-id-type="pmid">17621522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nandedkar</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Minus</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nandedkar</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Eruptive vellus hair cysts in a patient with Lowe syndrome.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2004</year>
            <season>Jan-Feb</season>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-7</page-range>
            <pub-id pub-id-type="pmid">14871328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodrigues Santos</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Manzano</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Masiero</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Oculocerebrorenal Lowe syndrome: a literature review and two case reports.</article-title>
            <source>Spec Care Dentist</source>
            <year>2007</year>
            <season>May-Jun</season>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>108</fpage>
            <page-range>108-11</page-range>
            <pub-id pub-id-type="pmid">17658186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbassi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Calcagno</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Oculo-cerebro-renal syndrome. A review.</article-title>
            <source>Am J Dis Child</source>
            <year>1968</year>
            <month>Feb</month>
            <volume>115</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-68</page-range>
            <pub-id pub-id-type="pmid">4865974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lasne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baujat</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mirault</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lunardi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grelac</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Egot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bachelot-Loza</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disorders.</article-title>
            <source>Br J Haematol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>150</volume>
            <issue>6</issue>
            <fpage>685</fpage>
            <page-range>685-8</page-range>
            <pub-id pub-id-type="pmid">20629659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Gould</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macri</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Charnas</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.</article-title>
            <source>Obstet Gynecol</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-80</page-range>
            <pub-id pub-id-type="pmid">7516514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tricot</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yahiaoui</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Teixeira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Benabdallah</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rothschild</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Juquel</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Satre</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gr&#x000fc;nfeld</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Chauveau</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>End-stage renal failure in Lowe syndrome.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>1923</fpage>
            <page-range>1923-5</page-range>
            <pub-id pub-id-type="pmid">12937245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140257.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tatsi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Papanikolaou</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Chartomatsidou</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Papoulidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Athanasiadis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Najdecki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Timotheou</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Lowe syndrome identified in the offspring of an oocyte donor who was an unknown carrier of a de novo mutation: a case report and review of the literature.</article-title>
            <source>J Med Case Rep</source>
            <year>2019</year>
            <month>Nov</month>
            <day>02</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>325</fpage>
            <pub-id pub-id-type="pmid">31676009</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
